Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) ConsortiumCourtney Meyer, Jonathan Nguyen, Steven Trinh et al.|The American Surgeon|2025Cited by 4
Filling the tank: A multicenter investigation of trauma survival after ultramassive transfusionZachary J Grady, Randi N. Smith, Jonathan Nguyen et al.|The Journal of Trauma: Injury, Infection, and Critical Care|2025Cited by 2
Development of an Early Mortality Risk Prediction Model for Patients Receiving Ultra-Massive Blood Product Transfusion Based on Clinically Accessible Data from 11 U.S. Trauma CentersZachary Grady, Randi N. Smith, Jonathan Nguyen et al.|SSRN Electronic Journal|2025Cited by 0
A Leg Up: Evaluating Ultramassive Transfusion after Extremity Vascular InjuryZachary J Grady, Randi N. Smith, Melike Harfouche et al.|Journal of the American College of Surgeons|2025Cited by 0